Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial

Eyal Amiel1, Bart Everts2, Daniel Fritz3

  • 1Department of Medical Laboratory and Radiation Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, VT 05405; Trudeau Institute, Saranac Lake, NY 12983; and.

Insights

Inhibiting mechanistic target of rapamycin (mTOR) extends the lifespan of Toll-like receptor (TLR)-activated dendritic cells (DCs). This preserves mitochondrial function and metabolic flexibility, enhancing DC efficacy in vaccination.

Area of Science:

  • Immunology
  • Cellular Metabolism
  • Molecular Biology

Background:

  • Toll-like receptor (TLR) activation induces metabolic changes in dendritic cells (DCs).
  • This involves inhibiting mitochondrial oxidative phosphorylation via nitric oxide (NO) and promoting aerobic glycolysis.
  • The mechanistic target of rapamycin (mTOR) pathway plays a role in regulating these metabolic shifts.

Purpose of the Study:

  • To investigate the role of mTOR in modulating DC metabolism and longevity.
  • To determine how mTOR inhibition affects metabolic flexibility and ATP production in TLR-activated DCs.
  • To provide mechanistic insights into enhanced DC efficacy in autologous vaccination following mTOR inhibition.

Main Methods:

  • Utilized TLR-activated dendritic cell models.
  • Assessed the impact of mechanistic target of rapamycin (mTOR) inhibition on NO production.
  • Analyzed cellular ATP production and nutrient utilization (glucose and fatty acids).
  • Evaluated the effect of mTOR inhibition on DC lifespan and function.

Main Results:

  • Inhibition of mechanistic target of rapamycin (mTOR) significantly extends the lifespan of Toll-like receptor (TLR)-activated dendritic cells (DCs).
  • mTOR inhibition prevents the induction of nitric oxide (NO) production, preserving mitochondrial oxidative phosphorylation.
  • This allows DCs to maintain ATP generation and utilize both fatty acids and glucose for metabolism.

Conclusions:

  • Mechanistic target of rapamycin (mTOR) inhibition modulates dendritic cell (DC) metabolism and cellular longevity post-Toll-like receptor (TLR) activation.
  • Preserving mitochondrial function and metabolic flexibility enhances DC efficacy, explaining benefits in autologous vaccination.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K